Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485.

Xu Q, Wang C, Meng Q, Liu Q, Sun H, Peng J, Ma X, Kaku T, Liu K.

Eur J Pharm Sci. 2013 Mar 12;48(4-5):650-7. doi: 10.1016/j.ejps.2012.12.024. Epub 2013 Jan 9.

PMID:
23313623
2.

Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3.

Ye J, Liu Q, Wang C, Meng Q, Peng J, Sun H, Kaku T, Liu K.

Eur J Pharm Sci. 2012 Sep 29;47(2):341-6. doi: 10.1016/j.ejps.2012.06.004. Epub 2012 Jun 21.

PMID:
22728397
3.

Effect of JBP485 on obstructive jaundice is related to regulation of renal Oat1, Oat3 and Mrp2 expression in ANIT-treated rats.

Liu T, Guo X, Meng Q, Wang C, Liu Q, Sun H, Ma X, Kaku T, Liu K.

Peptides. 2012 Jul;36(1):78-85. doi: 10.1016/j.peptides.2012.04.003. Epub 2012 Apr 11.

PMID:
22521734
4.

Organic anion transporters involved in the excretion of bestatin in the kidney.

Zhu Y, Meng Q, Wang C, Liu Q, Sun H, Kaku T, Liu K.

Peptides. 2012 Feb;33(2):265-71. doi: 10.1016/j.peptides.2012.01.007. Epub 2012 Jan 18.

PMID:
22273603
5.

Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats.

Feng Y, Wang C, Liu Q, Meng Q, Huo X, Liu Z, Sun P, Yang X, Sun H, Qin J, Liu K.

Eur J Pharm Sci. 2016 Jan 1;81:119-28. doi: 10.1016/j.ejps.2015.10.008. Epub 2015 Oct 22.

PMID:
26474691
6.

Inhibitory effect of 1α,25-dihydroxyvitamin D₃ on excretion of JBP485 via organic anion transporters in rats.

Miao Q, Liu Q, Wang C, Meng Q, Guo X, Sun H, Peng J, Ma X, Kaku T, Liu K.

Eur J Pharm Sci. 2013 Jan 23;48(1-2):351-9. doi: 10.1016/j.ejps.2012.11.008. Epub 2012 Nov 29.

PMID:
23201003
7.

Peptide cotransporter 1 in intestine and organic anion transporters in kidney are targets of interaction between JBP485 and lisinopril in rats.

Guo X, Meng Q, Liu Q, Wang C, Mao Q, Sun H, Peng J, Kaku T, Liu K.

Drug Metab Pharmacokinet. 2012;27(2):232-41. Epub 2011 Nov 29.

8.

PEPT1- and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human.

Wang L, Wang C, Liu Q, Meng Q, Huo X, Sun P, Yang X, Sun H, Zhen Y, Peng J, Ma X, Liu K.

Eur J Pharm Sci. 2014 Oct 15;63:77-86. doi: 10.1016/j.ejps.2014.06.019. Epub 2014 Jul 9.

PMID:
25016073
9.

Benzylpenicillin inhibits the renal excretion of acyclovir by OAT1 and OAT3.

Ye J, Liu Q, Wang C, Meng Q, Sun H, Peng J, Ma X, Liu K.

Pharmacol Rep. 2013;65(2):505-12.

10.

Changes in expression of renal Oat1, Oat3 and Mrp2 in cisplatin-induced acute renal failure after treatment of JBP485 in rats.

Liu T, Meng Q, Wang C, Liu Q, Guo X, Sun H, Peng J, Ma X, Kaku T, Liu K.

Toxicol Appl Pharmacol. 2012 Nov 1;264(3):423-30. doi: 10.1016/j.taap.2012.08.019. Epub 2012 Aug 27.

PMID:
22992436
11.

JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats.

Guo X, Meng Q, Liu Q, Wang C, Sun H, Peng J, Ma X, Kaku T, Liu K.

Toxicol Appl Pharmacol. 2013 Sep 1;271(2):285-95. doi: 10.1016/j.taap.2013.04.029. Epub 2013 May 23.

PMID:
23707770
12.

Pharmacokinetic interaction between JBP485 and cephalexin in rats.

Zhang J, Wang C, Liu Q, Meng Q, Cang J, Sun H, Gao Y, Kaku T, Liu K.

Drug Metab Dispos. 2010 Jun;38(6):930-8. doi: 10.1124/dmd.110.032060. Epub 2010 Mar 10.

13.

The oligopeptide transporter 2-mediated reabsorption of entecavir in rat kidney.

Xu Q, Wang C, Meng Q, Liu Q, Sun P, Sun H, Guo X, Liu K.

Eur J Pharm Sci. 2014 Feb 14;52:41-7. doi: 10.1016/j.ejps.2013.10.010. Epub 2013 Oct 30.

PMID:
24184752
14.

Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat.

Wang C, Wang C, Liu Q, Meng Q, Cang J, Sun H, Peng J, Ma X, Huo X, Liu K.

Drug Metab Dispos. 2014 Jun;42(6):996-1007. doi: 10.1124/dmd.113.055194. Epub 2014 Apr 1.

15.

Human organic anion transporter OAT1 is not responsible for glutathione transport but mediates transport of glutamate derivatives.

Hagos Y, Burckhardt G, Burckhardt BC.

Am J Physiol Renal Physiol. 2013 Feb 15;304(4):F403-9. doi: 10.1152/ajprenal.00412.2012. Epub 2012 Dec 19.

16.

Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs.

Cheng Y, Vapurcuyan A, Shahidullah M, Aleksunes LM, Pelis RM.

Drug Metab Dispos. 2012 Mar;40(3):617-24. doi: 10.1124/dmd.111.042036. Epub 2011 Dec 21.

17.

Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats.

Schneider R, Sauvant C, Betz B, Otremba M, Fischer D, Holzinger H, Wanner C, Galle J, Gekle M.

Am J Physiol Renal Physiol. 2007 May;292(5):F1599-605. Epub 2007 Jan 23.

18.

Inhibitory effect of valsartan on the intestinal absorption and renal excretion of bestatin in rats.

Huo X, Liu Q, Wang C, Meng Q, Sun H, Peng J, Ma X, Sun P, Liu K.

J Pharm Sci. 2014 Feb;103(2):719-29. doi: 10.1002/jps.23805. Epub 2013 Dec 11.

PMID:
24338900
19.

Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.

Maeda K, Tian Y, Fujita T, Ikeda Y, Kumagai Y, Kondo T, Tanabe K, Nakayama H, Horita S, Kusuhara H, Sugiyama Y.

Eur J Pharm Sci. 2014 Aug 1;59:94-103. doi: 10.1016/j.ejps.2014.04.004. Epub 2014 Apr 18.

PMID:
24747579
20.

Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney.

Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, Otagiri M, Sugiyama Y.

Pharm Res. 2005 Apr;22(4):647-60. Epub 2005 Apr 7.

PMID:
15846473

Supplemental Content

Support Center